Tyree James L
Insider CIK 1324991 · DEPO Director · THRX Director · GNLX Director · CCXI Director · ASRT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GNLX GENELUX Corp | A Award deriv | 2026-06-16 | 2026-06-18 | 31,566 | — | $0 | 31,566 | SEC↗ |
| GNLX GENELUX Corp | A Award | 2026-06-16 | 2026-06-18 | 28,409 | — | $0 | 96,483 | SEC↗ |
| GNLX GENELUX Corp | A Award deriv | 2025-08-27 | 2025-08-29 | 28,576 | — | $0 | 28,576 | SEC↗ |
| GNLX GENELUX Corp | A Award | 2025-08-27 | 2025-08-29 | 22,283 | — | $0 | 68,074 | SEC↗ |
| GNLX GENELUX Corp | S Sale | 2024-12-30 | 2024-12-30 | 3,460 | $2.46 | $8.5K | 45,791 | SEC↗ |
| GNLX GENELUX Corp | S Sale | 2024-09-11 | 2024-09-12 | 1,730 | $2.60 | $4.5K | 47,521 | SEC↗ |
| GNLX GENELUX Corp | A Award deriv | 2024-08-01 | 2024-12-31 | 50,469 | — | $0 | 50,469 | SEC↗ |
| GNLX GENELUX Corp | A Award deriv | 2024-08-01 | 2024-08-05 | 50,469 | — | $0 | 50,469 | SEC↗ |
| GNLX GENELUX Corp | A Award | 2024-08-01 | 2024-08-05 | 39,541 | — | $0 | 49,251 | SEC↗ |
| GNLX GENELUX Corp | P Buy deriv | 2024-05-29 | 2024-06-07 | 6,250 | — | $0 | 6,250 | SEC↗ |
| GNLX GENELUX Corp | P Buy | 2024-05-29 | 2024-06-07 | 6,250 | — | $0 | 9,710 | SEC↗ |
| ASRT Assertio Holdings, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 10,251 | $1.12 | $11.5K | 188,251 | SEC↗ |
| GNLX GENELUX Corp | S Sale | 2023-12-13 | 2023-12-14 | 5,653 | $12.91 | $73.0K | 6,807 | SEC↗ |
| GNLX GENELUX Corp | S Sale | 2023-12-13 | 2023-12-14 | 3,347 | $13.73 | $46.0K | 3,460 | SEC↗ |
| GNLX GENELUX Corp | A Award deriv | 2023-09-11 | 2023-09-13 | 4,397 | — | $0 | 4,397 | SEC↗ |
| GNLX GENELUX Corp | A Award | 2023-09-11 | 2023-09-13 | 3,460 | — | $0 | 12,460 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2023-05-10 | 2023-05-12 | 3,821 | — | $0 | 3,821 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2023-05-10 | 2023-05-12 | 31,194 | — | $0 | 198,502 | SEC↗ |
| ASRT Assertio Holdings, Inc. | S Sale | 2023-05-05 | 2023-05-05 | 43,143 | $6.00 | $258.9K | 167,308 | SEC↗ |
| GNLX GENELUX CORP | A Award | 2023-02-17 | 2023-05-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 8,342 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 4,504 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 12,287 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 13,352 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 12,500 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 15,723 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer | 2022-10-20 | 2022-10-24 | 9,138 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2022-08-04 | 2022-08-08 | 10,000 | $50.22 | $502.2K | 9,138 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2022-06-09 | 2022-06-13 | 59 | $26.22 | $1.5K | 19,138 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2022-06-09 | 2022-06-13 | 3,804 | $25.65 | $97.6K | 19,197 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 8,342 | — | $0 | 8,342 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 15,723 | — | $0 | 15,723 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2022-05-20 | 2022-05-24 | 7,726 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2022-05-20 | 2022-05-24 | 7,726 | — | $0 | 23,001 | SEC↗ |
| ASRT Assertio Holdings, Inc. | S Sale | 2022-05-12 | 2022-05-16 | 44,643 | $2.36 | $105.4K | 210,451 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2022-05-04 | 2022-05-06 | 86,286 | — | $0 | 255,094 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2021-12-17 | 2021-12-21 | 12,500 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2021-12-17 | 2021-12-21 | 25,000 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2021-12-17 | 2021-12-21 | 12,500 | $14.42 | $180.3K | 52,775 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2021-12-17 | 2021-12-21 | 25,000 | $12.62 | $315.5K | 40,275 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2021-12-17 | 2021-12-21 | 2,800 | $33.52 | $93.9K | 49,975 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2021-12-17 | 2021-12-21 | 16,634 | $34.74 | $577.9K | 33,341 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2021-12-17 | 2021-12-21 | 18,066 | $35.50 | $641.3K | 15,275 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2021-05-21 | 2021-05-24 | 4,660 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2021-05-21 | 2021-05-24 | 4,660 | — | $0 | 17,729 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2021-05-21 | 2021-05-24 | 2,454 | $9.76 | $24.0K | 15,275 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2021-05-20 | 2021-05-24 | 7,726 | — | $0 | 7,726 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2021-05-20 | 2021-05-24 | 4,504 | — | $0 | 4,504 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2021-05-11 | 2021-05-13 | 357,143 | — | $0 | 675,233 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2020-05-23 | 2020-05-26 | 7,724 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2020-05-23 | 2020-05-26 | 7,724 | — | $0 | 13,069 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 2,888 | — | $0 | 2,888 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 4,660 | — | $0 | 4,660 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2020-05-19 | 2020-05-21 | 237,500 | — | $0 | 318,090 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2020-01-13 | 2020-01-15 | 15,285 | $36.69 | $560.8K | 20,060 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2020-01-13 | 2020-01-15 | 14,715 | $37.44 | $550.9K | 5,345 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2019-05-23 | 2019-05-23 | 12,287 | — | $0 | 12,287 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2019-05-23 | 2019-05-23 | 7,724 | — | $0 | 7,724 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2019-05-21 | 2019-05-23 | 8,421 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2019-05-21 | 2019-05-23 | 8,421 | — | $0 | 35,345 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise deriv | 2019-05-08 | 2019-05-09 | 31,250 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise | 2019-05-08 | 2019-05-09 | 31,250 | — | $0 | 80,590 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | A Award | 2019-05-07 | 2019-05-09 | 39,584 | — | $0 | 49,340 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2018-05-21 | 2018-05-23 | 8,421 | — | $0 | 8,421 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2018-05-21 | 2018-05-23 | 13,352 | — | $0 | 13,352 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2018-05-08 | 2018-05-10 | 31,250 | — | $0 | 31,250 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2017-08-15 | 2017-08-16 | 19,512 | — | $0 | 19,512 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2017-05-26 | 2017-05-30 | 20,362 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2017-05-26 | 2017-05-30 | 20,362 | — | $0 | 53,849 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award | 2017-05-25 | 2017-05-30 | 12,912 | — | $0 | 33,487 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2017-04-20 | 2017-04-24 | 19,857 | — | $0 | 70,554 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2016-10-17 | 2016-10-19 | 18,485 | — | $0 | 18,485 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2016-05-26 | 2016-05-27 | 20,362 | — | $0 | 20,362 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2016-05-23 | 2016-05-24 | 5,544 | $4.39 | $24.3K | 20,575 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2016-05-21 | 2016-05-24 | 11,795 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2016-05-21 | 2016-05-24 | 11,795 | — | $0 | 26,119 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2016-05-18 | 2016-05-20 | 813 | $10.47 | $8.5K | 50,697 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2016-04-26 | 2016-04-27 | 18,328 | — | $0 | 53,948 | SEC↗ |
| THRX THERAVANCE INC | S Sale | 2015-06-02 | 2015-06-04 | 2,438 | $16.85 | $41.1K | 33,182 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2015-05-22 | 2015-05-26 | 27,027 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2015-05-22 | 2015-05-26 | 12,703 | $7.45 | $94.6K | 14,324 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2015-05-22 | 2015-05-26 | 27,027 | — | $0 | 27,027 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2015-05-21 | 2015-05-26 | 11,795 | — | $0 | 11,795 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2015-04-24 | 2015-04-27 | 13,950 | — | $0 | 35,620 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-12-22 | 2014-12-23 | 6,500 | — | $0 | 21,670 | SEC↗ |
| THRX THERAVANCE INC | A Award deriv | 2014-06-02 | 2014-06-04 | 6,000 | — | $0 | 6,000 | SEC↗ |
| THRX THERAVANCE INC | A Award deriv | 2014-06-02 | 2014-06-04 | 6,000 | — | $0 | 6,000 | SEC↗ |
| THRX THERAVANCE INC | A Award deriv | 2014-06-02 | 2014-06-09 | 7,585 | — | $0 | 7,585 | SEC↗ |
| THRX THERAVANCE INC | A Award deriv | 2014-06-02 | 2014-06-09 | 7,585 | — | $0 | 7,585 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-06-02 | 2014-06-04 | 6,000 | — | $0 | 6,000 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-06-02 | 2014-06-04 | 6,000 | — | $0 | 12,000 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-06-02 | 2014-06-09 | 7,585 | — | $0 | 15,170 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-06-02 | 2014-06-09 | 7,585 | — | $0 | 7,585 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2014-05-22 | 2014-05-23 | 27,027 | — | $0 | 27,027 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2013-05-23 | 2013-05-28 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2012-06-22 | 2012-06-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2012-06-05 | 2012-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |